J. Petersen

Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation

Marc Lütgehetmann, Lida V. Mancke, Tassilo Volz et al. · Hepatology · 2011 · 217 citations · Full text

Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infection

Markus Cornberg, J. Petersen, Andreas Schober et al. · Alimentary Pharmacology & Therapeutics · 2017 · 45 citations · Full text

P0772 : Daclatasvir plus sofosbuvir with or without ribavirin for the treatment of HCV in patients with severe liver disease: Interim results of a multicenter compassionate use program

Tania M. Welzel, Kerstin Herzer, Péter Ferenci et al. · Journal of Hepatology · 2015 · 39 citations

Hepatology, Viral Hepatitis, Liver Physiology +9

Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure

Julia Dietz, Beat Müllhaupt, Peter Buggisch et al. · Journal of Hepatology · 2022 · 23 citations

Viral Persistence, Viral Hepatitis, Immunology +7

Prevalence, Incidence, and Clinical Relevance of the Reverse Transcriptase V207I Mutation Outside the YMDD Motif of the Hepatitis B Virus Polymerase during Lamivudine Therapy

Bernhard Zöllner, Martina Sterneck, Karsten Wursthorn et al. · Journal of Clinical Microbiology · 2005 · 20 citations · Full text